Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial

June 07, 2024 00:22:24
Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial
Critical Care Perspectives in Emergency Medicine
Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial

Jun 07 2024 | 00:22:24

/

Show Notes

Timely and appropriate administration of empiric broad-spectrum antibiotics for adult patients with sepsis is critical.  Current guidelines recommend an antipseudomonal antibiotic for those at risk of a resistant gram-negative organism.  The two most common antipseudomonal antibiotics prescribed in this setting are cefepime and piperacillin-tazobactam.  In recent years, observational studies have reported an association with cefepime and neurotoxicity, whereas piperacillin-tazobactam has been associated with AKI especially when given with vancomycin.  In this podcast, we discuss the recently published ACORN Trial, a randomized trial that evaluated cefepime and piperacillin-tazobactam for adult patients with suspected infection.

Other Episodes

Episode 0

January 26, 2021 00:22:57
Episode Cover

The Critically Ill Patient with Aortic Stenosis

Patients with severe aortic stenosis who present with acute decompensated heart failure are among the most challenging patients to resuscitate.  In this podcast, we...

Listen

Episode 0

April 13, 2023 00:28:58
Episode Cover

Should We Administer Steroids in Severe CAP?

In recent years,  numerous trials have investigated the administration of corticosteroids in patients with pneumonia and have produced mixed results.  In this podcast, we...

Listen

Episode

April 24, 2024 00:18:44
Episode Cover

Are We Ventilating our OHCA Patients?

In recent years, there has been intense focus on delivering high-quality compressions during the resuscitation of patients with OHCA.  In contrast, ventilation metrics in...

Listen